Advertisement

Male Alopecia pp 223-237 | Cite as

Patient Expectation Management

  • Ralph M. Trüeb
  • Won-Soo Lee
Chapter

Abstract

Few dermatologic problems carry as much emotional overtones as the complaint of hair loss. Adding to some patient’s worry may be prior frustrating experiences with physicians, who tend to trivialize complaints of hair loss or dismiss them completely. This attitude on the part of physicians is related either to lack of comprehension of the impact of hair loss on quality of life or to lack of confidence in the treatment of alopecia.

Treatment options are available, though limited, both in terms of indications and of efficacy. Success depends not only on comprehension of the underlying pathology but also on unpatronizing sympathy from the part of the physician.

Keywords

Erectile Dysfunction Benign Prostatic Hyperplasia Hair Loss Alopecia Areata Dermatology Life Quality Index 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Further Reading

Evidence-Based Medicine

  1. Rawson E (1982) The life and death of asclepiades of bithynia. Class Q 32:358–370PubMedCrossRefGoogle Scholar

Listening to the Patient

  1. Cash TF (1992) The psychological effects of androgenetic alopecia in men. J Am Acad Dermatol 26:926–931PubMedCrossRefGoogle Scholar
  2. Cash TF (1999) The psychosocial consequences of androgenetic alopecia: a review of the research literature. Br J Dermatol 141:398–405PubMedCrossRefGoogle Scholar
  3. Maffei C, Fossati A, Rinaldi F, Riva E (1994) Personality disorders and psychopathologic symptoms in patients with androgenetic alopecia. Arch Dermatol 130:868–872PubMedCrossRefGoogle Scholar
  4. Neumann M, Scheffer C, Tauschel D, Lutz G, Wirtz M, Edelhäuser F (2012) Physician empathy: definition, outcome-relevance and its measurement in patient care and medical education. GMS Z Med Ausbild 29:Doc11PubMedCentralPubMedGoogle Scholar
  5. Teutsch C (2003) Patient-doctor communication. Med Clin North Am 87:1115–1145PubMedCrossRefGoogle Scholar
  6. Yamazaki M, Miyakura T, Uchiyama M, Hobo A, Irisawa R, Tsuboi R (2011) Oral finasteride improved the quality of life of androgenetic alopecia patients. J Dermatol 38:773–777PubMedCrossRefGoogle Scholar

Tackling Side Effects

  1. Altomare G, Capella GL (2002) Depression circumstantially related to the administration of finasteride for androgenetic alopecia. J Dermatol 29:665–669PubMedGoogle Scholar
  2. Baibergenova A, Walsh S (2012) Use of pioglitazone in patients with lichen planopilaris. J Cutan Med Surg 16:97–100PubMedGoogle Scholar
  3. Finn DA, Long SL, Tanchuck MA, Crabbe J (2004) Interaction of chronic ethanol exposure and finasteride: sex and strain differences. Pharmacol Biochem Behav 78:435–443PubMedCrossRefGoogle Scholar
  4. Georgala S, Befon A, Maniatopoulou E, Georgala C (2007) Topical use of minoxidil in children and systemic side effects. Dermatology 214:101–102PubMedCrossRefGoogle Scholar
  5. Glina S, Neves PA, Saade R, Netto NR Jr, Soares JB, Galuppo AG (2004) Finasteride-associated male infertility. Rev Hosp Clin Fac Med Sao Paulo 59:203–205PubMedCrossRefGoogle Scholar
  6. Gorin RE, Crabbe JC, Tanchuck MA, Long SL, Finn DA (2005) Effects of finasteride on chronic and acute ethanol withdrawal severity in the WSP and WSR selected lines. Alcohol Clin Exp Res 29:939–948PubMedCrossRefGoogle Scholar
  7. Hepp U, Kraemer B, Schnyder U, Miller N, Delsignore A (2005) Psychiatric comorbidity in gender identity disorder. J Psychosom Res 58:259–261PubMedCrossRefGoogle Scholar
  8. Irwig MS (2012) Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects. J Clin Psychiatry 73:1220–1223Google Scholar
  9. Irwig MS (2013) Decreased alcohol consumption among former male users of finasteride with persistent sexual side effects: a preliminary report. Alcohol Clin Exp Res doi: 10.1111/acer.12177. [Epub ahead of print]
  10. Irwig MS, Kolukula S (2011) Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med 8:1747–1753PubMedCrossRefGoogle Scholar
  11. Mirmirani P, Karnik P (2009) Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist. Arch Dermatol 145:1363–1366PubMedCentralPubMedCrossRefGoogle Scholar
  12. Morrow J (1999) New profits in old bottles; companies find bonus in drugs that cure several ills. The New York Times, 19 MarchGoogle Scholar
  13. Overstreet JW, Fuh VL, Gould J, Howards SS, Lieber MM, Hellstrom W, Shapiro S, Carroll P, Corfman RS, Petrou S, Lewis R, Toth P, Shown T, Roy J, Jarow JP, Bonilla J, Jacobsen CA, Wang DZ, Kaufman KD (1999) Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol 162:1295–1300PubMedCrossRefGoogle Scholar
  14. Ramot Y, Czarnowicki T, Zlotogorski A (2009) Finasteride induced gynecomastia: case report and review of the Literature. Int J Trichol 1:27–29CrossRefGoogle Scholar
  15. Ricci G, Martinelli M, Luppi S, Lo Bello L, De Santis M, Skerk K, Zito G (2012) Finasteride and fertility: case report and review of the literature. J Drugs Dermatol 11:1511–1513PubMedGoogle Scholar
  16. Rossi A, Cantisani C, Scarnò M, Trucchia A, Fortuna MC, Calvieri S (2011) Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up. Dermatol Ther 24:455–461PubMedCrossRefGoogle Scholar
  17. Sandomir R (2006) Skin deep; fighting baldness, and now an olympic ban. The New York Times, 19 JanuaryGoogle Scholar
  18. Sato A, Takeda A (2012) Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia. J Dermatol 39:27–32PubMedCrossRefGoogle Scholar
  19. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA Jr (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med 349:215–224PubMedCrossRefGoogle Scholar
  20. Thompson IM Jr, Goodman PJ, Tangen CM, Parnes HL, Minasian LM, Godley PA, Lucia MS, Ford LG (2013) Long-term survival of participants in the prostate cancer prevention trial. N Engl J Med 369:603–610PubMedCrossRefGoogle Scholar
  21. Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML (2011) Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients. J Sex Med 8:872–884PubMedCrossRefGoogle Scholar

Tackling Side Effects: Nocebo Effect

  1. Kennedy WP (1961) The nocebo reaction. Med World 95:203–205PubMedGoogle Scholar
  2. Mondaini N, Gontero P, Giubilei G, Lombardi G, Cai T, Gavazzi A, Bartoletti R (2007) Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? J Sex Med 4:1708–1712PubMedCrossRefGoogle Scholar

Tackling Side Effects: Post-finasteride Syndrome

  1. Irwig MS (2012) Persistent sexual side effects of finasteride: could they be permanent? J Sex Med 9:2927–2932Google Scholar
  2. LeFevre M (2013) A role for finasteride in the prevention of prostate cancer? N Engl J Med 369:670–671PubMedCrossRefGoogle Scholar

Cosmetic Camouflage and Hair Prosthesis

  1. Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J (2008) Interventions for alopecia areata. Cochrane Database Syst Rev (2):CD004413Google Scholar
  2. Draelos ZD (2013) Shampoos, conditioners, and camouflage techniques. Dermatol Clin 31:173–178PubMedGoogle Scholar
  3. Vandegrift KV (1994) The development of an oncology alopecia wig program. J Intraven Nurs 17:78–82PubMedGoogle Scholar
  4. van der Velden EM et al (1998) Dermatography as a new treatment for alopecia areata of the eyebrows. Int J Dermatol 37:617–621PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  • Ralph M. Trüeb
    • 1
  • Won-Soo Lee
    • 2
  1. 1.Center for Dermatology and Hair DiseasesWallisellen-ZurichSwitzerland
  2. 2.Department of DermatologyYonsei University Wonju College of MedicineWonju Kangwon-DoKorea Republic of (South Korea)

Personalised recommendations